NRNP 6665 FINAL EXAM TEST
QUESTIONS, NR 603 WEEK 7
(2026/2027) UPDATE|EXAM
QUESTIONS WITH MULTIPLE
CHOICES |VERIFIED & REVISED
ANSWERS (NEW)!!!
Questionm18:
Christinemismam9-year-
oldmfemalemwhompresentsmformcaremaftermhavingmbeenmplacedminmthemlocalmfostermcaremsystem.mSh
emhasmbeenminmandmoutmofmfostermcaremformthemlastm4myearsmaftermhermparentsmweremkilledminmanma
utomobilemaccident.mChristinemhasmbeenmplacedminmamvarietymofmhomesmandmresidentialmcaremfacil
ities.mThemPMHNPmrecognizesmthatmChristinemismatmhighmriskmfor:m-
mCORRECTmANSWERmA.mDissociativemdisordersm
B.mPost-traumaticmstressmdisorderm
C.mImpulse-controlmdisorderm
D.mAttachmentmdisorder
Questionm7:
Cayleemismam5-year-
oldmgirlmwhomismreferredmformevaluationmbymchildmprotectivemservices.mShemwasmrecentlymremoved
mfrommhermbiologicalmfamilymandmplacedminmfostermcare,masmhermhomemenvironmentmwasmreported
lymunsafemduemtomconditionsmofmextrememneglect.mHermfostermmothermreportsmthatmCayleemismvery
mquietmandmwithdrawnmandmalwaysmappearsmsadmandmdisinterestedminmhermsurroundings;mhoweve
r,mshembecomesmverymirritablemwhenmanythingmunexpectedmormunplannedmoccurs.mThemfostermmo
thermbecamemverymconcernedmwhenmitmappearedmthatmCayleemwasmhallucinating.mThemPMHNPmco
nsidersmthat:m-
mCORRECTmANSWERmA.mCayleemismatmhighmriskmformsuicidemandmprecautionsmshouldmbemtakenm
B.mThemhallucinationsmaremconsistentmwithmbriefmpsychoticmdisordermormschizophreniam
,C.mThemhistorymandmreportedmsymptomsmaremtypicalmofmdepressivemdisorderminmyoungmchildren
D.mThismismamcommonmsituationmwhenmprepubertalmchildrenmaremremovedmfrommthembiologicalmpa
rentsmregardlessmofmhowmdysfunctionalmtheymare
Questionm2:
mDebimismam15-year-
oldmgirlmwhomismcurrentlymbeingmtreatedmformdepression.mHermparentsmhavembeenmverymproactivem
andminvolvedminmhermcare,mandmDebimhasmachievedmremissionm2mmonthsmaftermbeginningmtreatme
ntmwithmamcombinationmofmpharmacotherapymandmcognitivembehavioralmtherapy.mWhilemcounselin
gmDebi'smparentsmaboutmimportantmissuesminmmanagement,mthemPMHNPmadvisesmthat:m-
mCORRECTmANSWERmA.mTheremismam>m50%mlikelihoodmthatmDebi'smyoungermsiblingmwillmdevelopmd
epressivemsymptomsm
B.mThemmeanmlengthmofmmajormdepressivemepisodeminmadolescentsmism4mmonthsm
C.m20mtom40%mofmadolescentsmwhomhavemmajormdepressivemdisordermwillmdevelopmbipolarmImwithi
nm5myearsm
D.mAdolescent-onsetmdepressionmtypicallymneedmlong-
termmpharmacologicmmanagementmtompreventmrelapses
Agomelatinem-mCORRECTmANSWERmBrand:mValdoxan
-Melatoninmmultimodalm(Mel-MM)
-Agonistmatmmelatonergicm1mandmmelatonergicm2mreceptors
-Antagonistmatm5HT2Cmreceptors
-NotmFDAmapproved:mRxmformDepression,mGeneralizedmanxietymdisorder
-Initialm25mmg/daymatmbedtime;mafterm2mweeksmcanmincreasemtom50mmg/daymatmbedtime
Amitriptylinem(Elavil)m-mCORRECTmANSWERmTricyclicmantidepressant.
Aripiprazolem(Abilify)m-
mCORRECTmANSWERmTreatmentmformdepression.mAtypicalmantipsychotic.m"Dopaminemstabilizer".m
,Dopaminemreceptormantagonistminmhighmconcentrationmandmalsomstimulatesmincreasemofmdopamin
eminmlowmconcentrations.mSidemeffects:minsomnia,makathisia.
Brexpiprazolem(Rexulti)m-mCORRECTmANSWERmTreatmentmformdepression.mAtypicalmantipsychotic
Bupropionm(Wellbutrin)m-
mCORRECTmANSWERmAntidepressantmandmsmokingmcessationmaid,mItmcanmtreatmdepressionmandmh
elpmpeoplemquitmsmoking.mItmcanmalsompreventmdepressionmcausedmbymseasonalmaffectivemdisorde
rm(SAD).
Citalopramm(Celexa)m-mCORRECTmANSWERmAntidepressant,mSSRI:m20-40mmgmqd.
Clomipraminem(Anafranil)m-mCORRECTmANSWERm-Serotoninmreuptakeminhibitorm(S-RI)
-Tricyclicmantidepressantm(TCA)
-Parentmdrugmismampotentmserotoninmreuptakeminhibitor
Activemmetabolitemismampotentmnorepinephrine/noradrenalinemreuptakeminhibitor
-
Increasesmserotonergicmneurotransmissionmbymblockingmthemserotoninmreuptakempumpm(transpor
ter),m-Desensitizationmofmserotoninmreceptors,mespeciallymserotoninm1Amreceptors
-
Increasesmnoradrenergicmneurotransmissionmbymblockingmthemnorepinephrinemreuptakempumpm(t
ransporter),m-Desensitizationmofmbetamadrenergicmreceptors
-Dopaminemisminactivatedmbymnorepinephrinemreuptakeminmthemfrontalmcortex
-Lacksmdopaminemtransporters
-Increasesmdopaminemneurotransmissionminmthismpartmofmthembrain
**FDAmApprovedmformPediatricsminmtxmObsessive-
compulsivemdisorderm(OCD)m(agesm10mandmolder)
*Off-LabelmformPediatricmUse:mDepression,mSeveremandmtreatment-
resistant,mdepression,mCataplexymsyndrome,mAnxiety,mInsomnia,
, Neuropathicmpain/chronicmpain
-Fullmtherapeuticmbenefitsmmaymtakem2-8mweeks
-Dosing:minmPeds/Adolescents/Adults:
100-250mg/day
Cyamemazinem(Tercian)m-mCORRECTmANSWERmTreatmentmformdepression.
m -Knownmasmcyamepromazine
m -Typicalmantipsychoticmdrugmofmthemphenothiazinemclass.m
m -Treatmentmformschizophrenia
m andmpsychosis-associated
m anxiety
-Behavesmlikemanmatypical
m antipsychotic,mduemtomits
m potentmanxiolyticmeffectsm(5-HT2C)mandmlackmofmextrapyramidalmsidemeffectsm(5-HT2A).
-
Conventionalmantipsychoticm(neuroleptic,mphenothiazine,mdopaminem2mantagonist,mserotoninmdo
paminemantagonist)
-CommonlymPrescribedmform(notmFDAmapproved):
m -Schizophrenia
m -Anxietymassociatedmwithmpsychosism(short-term)
m-
Anxietymassociatedmwithmnonpsychoticmdisorders,mincludingmmoodmdisordersmandmpersonalitymdis
ordersm(short-term)
m -Severemdepression
m -Bipolarmdisorder
m -Othermpsychoticmdisorders
m -Acutemagitation/aggressionm(injection)
QUESTIONS, NR 603 WEEK 7
(2026/2027) UPDATE|EXAM
QUESTIONS WITH MULTIPLE
CHOICES |VERIFIED & REVISED
ANSWERS (NEW)!!!
Questionm18:
Christinemismam9-year-
oldmfemalemwhompresentsmformcaremaftermhavingmbeenmplacedminmthemlocalmfostermcaremsystem.mSh
emhasmbeenminmandmoutmofmfostermcaremformthemlastm4myearsmaftermhermparentsmweremkilledminmanma
utomobilemaccident.mChristinemhasmbeenmplacedminmamvarietymofmhomesmandmresidentialmcaremfacil
ities.mThemPMHNPmrecognizesmthatmChristinemismatmhighmriskmfor:m-
mCORRECTmANSWERmA.mDissociativemdisordersm
B.mPost-traumaticmstressmdisorderm
C.mImpulse-controlmdisorderm
D.mAttachmentmdisorder
Questionm7:
Cayleemismam5-year-
oldmgirlmwhomismreferredmformevaluationmbymchildmprotectivemservices.mShemwasmrecentlymremoved
mfrommhermbiologicalmfamilymandmplacedminmfostermcare,masmhermhomemenvironmentmwasmreported
lymunsafemduemtomconditionsmofmextrememneglect.mHermfostermmothermreportsmthatmCayleemismvery
mquietmandmwithdrawnmandmalwaysmappearsmsadmandmdisinterestedminmhermsurroundings;mhoweve
r,mshembecomesmverymirritablemwhenmanythingmunexpectedmormunplannedmoccurs.mThemfostermmo
thermbecamemverymconcernedmwhenmitmappearedmthatmCayleemwasmhallucinating.mThemPMHNPmco
nsidersmthat:m-
mCORRECTmANSWERmA.mCayleemismatmhighmriskmformsuicidemandmprecautionsmshouldmbemtakenm
B.mThemhallucinationsmaremconsistentmwithmbriefmpsychoticmdisordermormschizophreniam
,C.mThemhistorymandmreportedmsymptomsmaremtypicalmofmdepressivemdisorderminmyoungmchildren
D.mThismismamcommonmsituationmwhenmprepubertalmchildrenmaremremovedmfrommthembiologicalmpa
rentsmregardlessmofmhowmdysfunctionalmtheymare
Questionm2:
mDebimismam15-year-
oldmgirlmwhomismcurrentlymbeingmtreatedmformdepression.mHermparentsmhavembeenmverymproactivem
andminvolvedminmhermcare,mandmDebimhasmachievedmremissionm2mmonthsmaftermbeginningmtreatme
ntmwithmamcombinationmofmpharmacotherapymandmcognitivembehavioralmtherapy.mWhilemcounselin
gmDebi'smparentsmaboutmimportantmissuesminmmanagement,mthemPMHNPmadvisesmthat:m-
mCORRECTmANSWERmA.mTheremismam>m50%mlikelihoodmthatmDebi'smyoungermsiblingmwillmdevelopmd
epressivemsymptomsm
B.mThemmeanmlengthmofmmajormdepressivemepisodeminmadolescentsmism4mmonthsm
C.m20mtom40%mofmadolescentsmwhomhavemmajormdepressivemdisordermwillmdevelopmbipolarmImwithi
nm5myearsm
D.mAdolescent-onsetmdepressionmtypicallymneedmlong-
termmpharmacologicmmanagementmtompreventmrelapses
Agomelatinem-mCORRECTmANSWERmBrand:mValdoxan
-Melatoninmmultimodalm(Mel-MM)
-Agonistmatmmelatonergicm1mandmmelatonergicm2mreceptors
-Antagonistmatm5HT2Cmreceptors
-NotmFDAmapproved:mRxmformDepression,mGeneralizedmanxietymdisorder
-Initialm25mmg/daymatmbedtime;mafterm2mweeksmcanmincreasemtom50mmg/daymatmbedtime
Amitriptylinem(Elavil)m-mCORRECTmANSWERmTricyclicmantidepressant.
Aripiprazolem(Abilify)m-
mCORRECTmANSWERmTreatmentmformdepression.mAtypicalmantipsychotic.m"Dopaminemstabilizer".m
,Dopaminemreceptormantagonistminmhighmconcentrationmandmalsomstimulatesmincreasemofmdopamin
eminmlowmconcentrations.mSidemeffects:minsomnia,makathisia.
Brexpiprazolem(Rexulti)m-mCORRECTmANSWERmTreatmentmformdepression.mAtypicalmantipsychotic
Bupropionm(Wellbutrin)m-
mCORRECTmANSWERmAntidepressantmandmsmokingmcessationmaid,mItmcanmtreatmdepressionmandmh
elpmpeoplemquitmsmoking.mItmcanmalsompreventmdepressionmcausedmbymseasonalmaffectivemdisorde
rm(SAD).
Citalopramm(Celexa)m-mCORRECTmANSWERmAntidepressant,mSSRI:m20-40mmgmqd.
Clomipraminem(Anafranil)m-mCORRECTmANSWERm-Serotoninmreuptakeminhibitorm(S-RI)
-Tricyclicmantidepressantm(TCA)
-Parentmdrugmismampotentmserotoninmreuptakeminhibitor
Activemmetabolitemismampotentmnorepinephrine/noradrenalinemreuptakeminhibitor
-
Increasesmserotonergicmneurotransmissionmbymblockingmthemserotoninmreuptakempumpm(transpor
ter),m-Desensitizationmofmserotoninmreceptors,mespeciallymserotoninm1Amreceptors
-
Increasesmnoradrenergicmneurotransmissionmbymblockingmthemnorepinephrinemreuptakempumpm(t
ransporter),m-Desensitizationmofmbetamadrenergicmreceptors
-Dopaminemisminactivatedmbymnorepinephrinemreuptakeminmthemfrontalmcortex
-Lacksmdopaminemtransporters
-Increasesmdopaminemneurotransmissionminmthismpartmofmthembrain
**FDAmApprovedmformPediatricsminmtxmObsessive-
compulsivemdisorderm(OCD)m(agesm10mandmolder)
*Off-LabelmformPediatricmUse:mDepression,mSeveremandmtreatment-
resistant,mdepression,mCataplexymsyndrome,mAnxiety,mInsomnia,
, Neuropathicmpain/chronicmpain
-Fullmtherapeuticmbenefitsmmaymtakem2-8mweeks
-Dosing:minmPeds/Adolescents/Adults:
100-250mg/day
Cyamemazinem(Tercian)m-mCORRECTmANSWERmTreatmentmformdepression.
m -Knownmasmcyamepromazine
m -Typicalmantipsychoticmdrugmofmthemphenothiazinemclass.m
m -Treatmentmformschizophrenia
m andmpsychosis-associated
m anxiety
-Behavesmlikemanmatypical
m antipsychotic,mduemtomits
m potentmanxiolyticmeffectsm(5-HT2C)mandmlackmofmextrapyramidalmsidemeffectsm(5-HT2A).
-
Conventionalmantipsychoticm(neuroleptic,mphenothiazine,mdopaminem2mantagonist,mserotoninmdo
paminemantagonist)
-CommonlymPrescribedmform(notmFDAmapproved):
m -Schizophrenia
m -Anxietymassociatedmwithmpsychosism(short-term)
m-
Anxietymassociatedmwithmnonpsychoticmdisorders,mincludingmmoodmdisordersmandmpersonalitymdis
ordersm(short-term)
m -Severemdepression
m -Bipolarmdisorder
m -Othermpsychoticmdisorders
m -Acutemagitation/aggressionm(injection)
